Search Results

G-749 50 mg  | 98.32%

TargetMol

G-749, a new-type FLT3 inhibitor, exhibits effective and sustained inhibition of the FLT3 wild type and mutants.

More Information Supplier Page

G-749 5 mg  | 98.32%

TargetMol

G-749, a new-type FLT3 inhibitor, exhibits effective and sustained inhibition of the FLT3 wild type and mutants.

More Information Supplier Page

UNC2881 10 mg  | 99.72%

TargetMol

UNC2881 is a specific Mer tyrosine kinase inhibitor (IC50: 4.3 nM). It is about 83- and 58-fold higher selectivity than Axl and Tyro3, respectively.

More Information Supplier Page

Spebrutinib 100 mg  | 97.14%

TargetMol

Spebrutinib is an orally bioavailable, selective inhibitor of Bruton’s agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity.

More Information Supplier Page

Norgestrel 50 mg  | 99.79%

TargetMol

Norgestrel is a synthetic progestin commonly used alone or in combination with an estrogen for contraception. Norgestrel suppresses the secretion of luteinizing and follicle-stimulating hormones (LH and FSH), thickens cervical mucus, and slows the transit of ova through the fallopian tubes.

More Information Supplier Page

Norgestrel 100 mg  | 99.79%

TargetMol

Norgestrel is a synthetic progestin commonly used alone or in combination with an estrogen for contraception. Norgestrel suppresses the secretion of luteinizing and follicle-stimulating hormones (LH and FSH), thickens cervical mucus, and slows the transit of ova through the fallopian tubes.

More Information Supplier Page